- Home
- LSAK vs BLDE Comparison
LSAK vs BLDE Comparison
Compare LSAK & BLDE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- LSAK
- BLDE
- Stock Information
- Founded
- LSAK 1997
- BLDE 2014
- Country
- LSAK South Africa
- BLDE United States
- Employees
- LSAK N/A
- BLDE N/A
- Industry
- LSAK Investment Bankers/Brokers/Service
- BLDE Aerospace
- Sector
- LSAK Finance
- BLDE Consumer Discretionary
- Exchange
- LSAK Nasdaq
- BLDE Nasdaq
- Market Cap
- LSAK N/A
- BLDE 276.7M
- IPO Year
- LSAK N/A
- BLDE N/A
- Fundamental
- Price
- LSAK $5.10
- BLDE $3.74
- Analyst Decision
- LSAK
- BLDE
- Analyst Count
- LSAK 0
- BLDE 0
- Target Price
- LSAK N/A
- BLDE N/A
- AVG Volume (30 Days)
- LSAK 18.4K
- BLDE 511.6K
- Earning Date
- LSAK 11-06-2024
- BLDE 11-12-2024
- Dividend Yield
- LSAK N/A
- BLDE N/A
- EPS Growth
- LSAK N/A
- BLDE N/A
- EPS
- LSAK N/A
- BLDE N/A
- Revenue
- LSAK $564,222,000.00
- BLDE $238,379,000.00
- Revenue This Year
- LSAK $6.62
- BLDE $12.14
- Revenue Next Year
- LSAK $7.87
- BLDE $11.35
- P/E Ratio
- LSAK N/A
- BLDE N/A
- Revenue Growth
- LSAK 6.87
- BLDE 25.39
- 52 Week Low
- LSAK $3.00
- BLDE $2.06
- 52 Week High
- LSAK $5.33
- BLDE $4.25
- Technical
- Relative Strength Index (RSI)
- LSAK 58.96
- BLDE 66.84
- Support Level
- LSAK $4.99
- BLDE $3.41
- Resistance Level
- LSAK $5.08
- BLDE $3.54
- Average True Range (ATR)
- LSAK 0.11
- BLDE 0.15
- MACD
- LSAK 0.01
- BLDE 0.03
- Stochastic Oscillator
- LSAK 100.00
- BLDE 83.20
About BLDE Blade Air Mobility Inc.
Blade Air Mobility Inc is a technology-powered air mobility platform that provides air transportation and logistics for hospitals and is a transporter of human organs for transplant, and for passengers, with helicopter and fixed-wing services predominantly in the Northeast United States, Southern Europe and Western Canada. The company's operating segments are; Passenger, and Medical. Majority of the revenue for the company is generated from its Medical segment which predominantly consists of transportation of human organs for transplant and the medical teams supporting these services. It also offers additional services including donor logistics coordination and support in evaluating potential donor organs. A substantial portion of the company's revenue is generated from the United States.